MEDP
Medpace Holdings, Inc. NASDAQ Listed Aug 11, 2016$429.02
Mkt Cap $12.3B
52w Low $284.48
42.0% of range
52w High $628.92
50d MA $465.95
200d MA $514.15
P/E (TTM)
26.7x
EV/EBITDA
28.0x
P/B
26.2x
Debt/Equity
0.6x
ROE
77.0%
P/FCF
23.8x
RSI (14)
—
ATR (14)
—
Beta
1.39
50d MA
$465.95
200d MA
$514.15
Avg Volume
428.4K
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
5375 Medpace Way · Cincinnati, OH 45227 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | AMC | 3.74 | 4.28 | +14.4% | 508.46 | -26.2% | -22.6% | +4.4% | +2.6% | -2.8% | +1.0% | — |
| Feb 9, 2026 | AMC | 4.19 | 4.67 | +11.5% | 530.35 | -7.8% | -15.9% | -5.0% | -1.9% | +2.9% | +0.0% | — |
| Oct 22, 2025 | AMC | 3.53 | 3.86 | +9.3% | 546.74 | +13.3% | +9.1% | +1.4% | -1.4% | -2.7% | +0.7% | — |
| Jul 21, 2025 | AMC | 2.98 | 3.10 | +4.0% | 308.88 | +44.3% | +54.7% | -8.4% | +4.2% | -1.8% | +1.2% | — |
| Apr 21, 2025 | AMC | 3.06 | 3.67 | +19.9% | 288.99 | -10.3% | -2.3% | +2.9% | +4.2% | -1.4% | -0.1% | — |
| Feb 10, 2025 | AMC | 2.96 | 3.67 | +24.0% | 354.51 | -3.9% | -7.5% | +2.6% | +1.8% | -0.7% | +0.2% | — |
| Oct 21, 2024 | AMC | 2.78 | 3.01 | +8.3% | 352.92 | -13.6% | -7.5% | +1.1% | -0.6% | +0.7% | -0.3% | — |
| Jul 22, 2024 | AMC | 2.54 | 2.75 | +8.3% | 437.18 | -17.5% | -18.3% | +6.9% | -0.4% | +0.3% | +1.0% | — |
| Apr 22, 2024 | AMC | 2.47 | 3.20 | +29.6% | 376.26 | +0.5% | +8.2% | -2.4% | -2.0% | +1.6% | +1.1% | — |
| Feb 12, 2024 | AMC | 2.22 | 2.46 | +10.8% | 324.21 | +0.8% | +12.3% | +7.1% | +1.2% | -0.7% | -1.9% | — |
| Oct 23, 2023 | AMC | 2.05 | 2.22 | +8.3% | 227.52 | +9.9% | +19.7% | -5.1% | -1.0% | -2.2% | -3.4% | — |
| Jul 24, 2023 | AMC | 1.91 | 1.93 | +1.0% | 246.94 | -6.9% | +3.9% | -0.0% | -3.0% | +2.4% | -0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | Baird | Maintains | Outperform → Outperform | — | $393.42 | $390.01 | -0.9% | +4.4% | +2.6% | -2.8% | +1.0% | +1.2% |
| Apr 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $393.42 | $390.01 | -0.9% | +4.4% | +2.6% | -2.8% | +1.0% | +1.2% |
| Apr 24 | RBC Capital | Maintains | Outperform → Outperform | — | $393.42 | $390.01 | -0.9% | +4.4% | +2.6% | -2.8% | +1.0% | +1.2% |
| Apr 24 | BMO Capital | Maintains | Market Perform → Market Perform | — | $393.42 | $390.01 | -0.9% | +4.4% | +2.6% | -2.8% | +1.0% | +1.2% |
| Mar 6 | Barclays | Upgrade | Underweight → Equal Weight | — | $469.38 | $469.50 | +0.0% | +0.3% | +1.7% | -2.5% | +2.3% | -7.1% |
| Feb 18 | TD Cowen | Upgrade | Sell → Hold | — | $428.18 | $432.16 | +0.9% | +4.2% | +0.1% | +1.6% | -1.9% | -0.6% |
| Feb 13 | Jefferies | Upgrade | Hold → Buy | — | $416.04 | $421.45 | +1.3% | +2.9% | +0.0% | +4.2% | +0.1% | +1.6% |
| Feb 11 | Barclays | Maintains | Underweight → Underweight | — | $446.05 | $446.83 | +0.2% | -5.0% | -1.9% | +2.9% | +0.0% | +4.2% |
| Feb 11 | Truist | Maintains | Hold → Hold | — | $446.05 | $446.83 | +0.2% | -5.0% | -1.9% | +2.9% | +0.0% | +4.2% |
| Feb 11 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $446.05 | $446.83 | +0.2% | -5.0% | -1.9% | +2.9% | +0.0% | +4.2% |
| Dec 15 | Barclays | Maintains | Underweight → Underweight | — | $557.90 | $557.90 | +0.0% | +0.2% | -0.1% | -0.3% | +0.6% | +1.5% |
| Oct 27 | Truist | Maintains | Hold → Hold | — | $605.20 | $606.59 | +0.2% | -1.4% | -2.7% | +0.7% | -0.7% | +0.8% |
| Oct 24 | Mizuho | Maintains | Outperform → Outperform | — | $596.61 | $603.05 | +1.1% | +1.4% | -1.4% | -2.7% | +0.7% | -0.7% |
| Oct 24 | TD Cowen | Maintains | Sell → Sell | — | $596.61 | $603.05 | +1.1% | +1.4% | -1.4% | -2.7% | +0.7% | -0.7% |
| Oct 24 | Barclays | Maintains | Underweight → Underweight | — | $596.61 | $603.05 | +1.1% | +1.4% | -1.4% | -2.7% | +0.7% | -0.7% |
| Oct 17 | Mizuho | Maintains | Outperform → Outperform | — | $521.21 | $520.49 | -0.1% | +1.3% | +3.1% | +0.2% | +0.2% | +9.1% |
| Oct 2 | Barclays | Downgrade | Equal Weight → Underweight | — | $543.90 | $525.75 | -3.3% | -1.4% | -0.7% | -0.4% | +0.3% | -0.2% |
| Sep 9 | Jefferies | Maintains | Hold → Hold | — | $492.09 | $491.37 | -0.1% | -1.3% | -1.8% | +4.4% | -1.4% | +1.2% |
| Sep 3 | Rothschild & Co | Downgrade | Buy → Neutral | — | $473.34 | $468.09 | -1.1% | +1.7% | +0.2% | +1.0% | +1.0% | -1.3% |
| Jul 29 | UBS | Downgrade | Neutral → Sell | — | $453.05 | $431.89 | -4.7% | -1.1% | -2.3% | -2.4% | -1.0% | +2.2% |
| Jul 25 | Mizuho | Maintains | Outperform → Outperform | — | $455.68 | $445.00 | -2.3% | -1.8% | +1.2% | -1.1% | -2.3% | -2.4% |
| Jul 23 | Deutsche Bank | Maintains | Hold → Hold | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Jul 23 | TD Cowen | Downgrade | Hold → Sell | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Jul 23 | Barclays | Maintains | Equal Weight → Equal Weight | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Jul 23 | Baird | Maintains | Neutral → Neutral | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Jul 23 | Truist | Maintains | Hold → Hold | — | $477.73 | $470.70 | -1.5% | -8.4% | +4.2% | -1.8% | +1.2% | -1.1% |
| Apr 23 | Baird | Maintains | Neutral → Neutral | — | $282.28 | $293.42 | +3.9% | +2.9% | +4.2% | -1.4% | -0.1% | +2.7% |
| Apr 23 | Truist | Maintains | Hold → Hold | — | $282.28 | $293.42 | +3.9% | +2.9% | +4.2% | -1.4% | -0.1% | +2.7% |
| Apr 22 | William Blair | Downgrade | Outperform → Market Perform | — | $288.99 | $259.13 | -10.3% | -2.3% | +2.9% | +4.2% | -1.4% | -0.1% |
| Apr 14 | TD Cowen | Downgrade | Buy → Hold | — | $297.72 | $298.42 | +0.2% | +2.5% | -0.1% | -2.8% | -0.1% | -2.5% |
| Apr 10 | Truist | Maintains | Hold → Hold | — | $302.56 | $297.85 | -1.6% | -6.7% | +5.5% | +2.5% | -0.1% | -2.8% |
| Apr 9 | Mizuho | Maintains | Outperform → Outperform | — | $277.23 | $274.58 | -1.0% | +9.1% | -6.7% | +5.5% | +2.5% | -0.1% |
| Jan 27 | Baird | Maintains | Neutral → Neutral | — | $344.07 | $343.47 | -0.2% | +1.8% | -1.3% | -0.8% | +2.0% | -0.3% |
| Nov 25 | Baird | Maintains | Neutral → Neutral | — | $337.75 | $341.65 | +1.2% | +0.0% | -0.8% | +1.1% | +0.5% | +0.5% |
| Oct 23 | TD Cowen | Maintains | Buy → Buy | — | $326.54 | $326.49 | -0.0% | +1.1% | -0.6% | +0.7% | -0.3% | +0.1% |
| Oct 23 | Baird | Downgrade | Outperform → Neutral | — | $326.54 | $326.49 | -0.0% | +1.1% | -0.6% | +0.7% | -0.3% | +0.1% |
| Oct 14 | Truist | Maintains | Hold → Hold | — | $347.91 | $350.00 | +0.6% | +1.6% | -0.1% | -1.9% | -1.0% | +3.9% |
| Sep 27 | UBS | Downgrade | Buy → Neutral | — | $326.26 | $322.09 | -1.3% | +1.6% | +0.7% | -0.1% | +1.0% | +0.3% |
| Sep 25 | Jefferies | Downgrade | Buy → Hold | — | $355.82 | $346.07 | -2.7% | -9.9% | +1.8% | +1.6% | +0.7% | -0.1% |
| Sep 20 | Baird | Maintains | Outperform → Outperform | — | $369.18 | $367.98 | -0.3% | -0.9% | -1.0% | -1.7% | -9.9% | +1.8% |
| Jul 24 | TD Cowen | Maintains | Buy → Buy | — | $357.30 | $357.30 | +0.0% | +6.9% | -0.4% | +0.3% | +1.0% | -1.8% |
| Jul 24 | Deutsche Bank | Maintains | Hold → Hold | — | $357.30 | $357.30 | +0.0% | +6.9% | -0.4% | +0.3% | +1.0% | -1.8% |
| Jul 24 | Guggenheim | Maintains | Buy → Buy | — | $357.30 | $357.30 | +0.0% | +6.9% | -0.4% | +0.3% | +1.0% | -1.8% |
| Jul 24 | Baird | Maintains | Outperform → Outperform | — | $357.30 | $357.30 | +0.0% | +6.9% | -0.4% | +0.3% | +1.0% | -1.8% |
| Jul 8 | Baird | Maintains | Outperform → Outperform | — | $402.40 | $404.75 | +0.6% | +0.8% | +1.3% | +2.0% | +3.8% | +1.8% |
| Apr 24 | Guggenheim | Maintains | Buy → Buy | — | $407.15 | $415.00 | +1.9% | -2.4% | -2.0% | +1.6% | +1.1% | -3.0% |
| Apr 24 | Baird | Maintains | Outperform → Outperform | — | $407.15 | $415.00 | +1.9% | -2.4% | -2.0% | +1.6% | +1.1% | -3.0% |
| Apr 23 | Jefferies | Upgrade | Hold → Buy | — | $376.26 | $378.00 | +0.5% | +8.2% | -2.4% | -2.0% | +1.6% | +1.1% |
| Mar 8 | UBS | Maintains | Buy → Buy | — | $409.63 | $413.40 | +0.9% | -1.0% | -0.6% | +1.0% | +0.1% | -0.8% |
| Feb 15 | UBS | Upgrade | Neutral → Buy | — | $389.80 | $390.00 | +0.1% | +1.2% | -0.7% | -1.9% | +0.6% | +1.9% |
No insider trades available.
8-K · 5.02
!!! Very High
Medpace Holdings, Inc. -- 8-K 5.02: Executive Change
Jesse Geiger's resignation as President of Medpace Holdings, effective May 31, 2026, signals upcoming leadership transition that investors should monitor for potential operational strategy changes and successor announcement.
Apr 22
8-K
Medpace Holdings, Inc. -- 8-K Filing
Medpace Holdings achieved strong 32% revenue growth in Q4 2025 to $708.5 million, demonstrating robust business momentum and effective backlog conversion at a 23.6% rate.
Feb 9
Data updated apr 26, 2026 11:47am
· Source: massive.com